Kera Capital Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Kera Capital Partners, Inc.
- $347 Billion
- Q4 2024
A detailed history of Kera Capital Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 1,332 shares of CRL stock, worth $219,780. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,332Holding current value
$219,780% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
707Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$840 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$673 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$360 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$298 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.39B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...